Glenmark Pharmaceuticals Ltd.

NSE: GLENMARK | BSE: 532296

Strong Performer, Getting Expensive

Download real time

2051.90 61.00 (3.06%)

60.87% Gain from 52W Low

995.8K NSE+BSE Volume

NSE 05 Sep, 2025 3:31 PM (IST)

57,904.8

Market Cap

High in industry

0.7

Beta 1Year

Very Low volatility

Dividend

Glenmark Pharmaceuticals Ltd. has an upcoming dividend of ₹2.50 per share due on 15 Sep 2025 See details

Glenmark Pharmaceuticals Ltd. share price target and research reports

Latest analyst research reports with target prices and PDF download for GLENMARK, BSE:532296 Glenmark Pharmaceuticals Ltd.

Is Glenmark Pharmaceuticals Ltd. worth buying?

571 Votes:

Buy 79.33%

Sell 13.66%

Hold 7.01%

RESEARCH REPORTS

Buy SEE REPORTS >

Sell SEE REPORTS >